Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14b02369b953bf4ebd31190c8cb63473 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-02 |
filingDate |
2002-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42be59eea9cc70fe3cdf03d3e4b3cd79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2811043a438d348cfe1f4adbf75a22a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c1ec8c42d6c98e07d4bd676643fadc7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fda2bff8ab09b1afec780495d4f80949 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_643623ee174a5d187af4bffaf12720f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b69a48e91d41c95828c45425fc7a59c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04bdf47ef2434c6cf87a0dda11ead45d |
publicationDate |
2004-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1408045-A1 |
titleOfInvention |
Novel galactosylceramide analogs and beta-glucocerebrosidase activators,external skin preparations and method of activating beta-glucocerebrosidase using the analogs |
abstract |
Galactosylceramide analogues represented by the followingnformula (1) or (2).n n n(wherein X and Y each represent S or O, R 1 and R 2 eachnrepresent an alkyl group or an alkenyl group each having 9nto 35 carbon atoms. R 3 represents an alkyl group or annalkenyl group each having 2 to 30 carbon atoms.) n It is provided a β-glucocerebrosidase activator whichnis easily available, and external skin preparations and anmethod of activating β-glucocerebrosidase, in whichnimprovement in formation of horny layer transmissionnbarrier is expected by activating β-glucocerebrosidase sonthat an improved effect in rough skin is also expected. |
priorityDate |
2001-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |